Ordering an oligonucleotide well: how scale, purification and modification decide the price rather than the base count, what separates oligonucleotide suppliers and oligonucleotide manufacturing companies once you compare like for like, when custom dna oligos, dna oligos, a dna oligo, a dna oligonucleotide, dna oligonucleotides, custom oligonucleotides, an rna oligonucleotide, rna oligonucleotides, custom rna oligos, oligo dna in a catalogue's shorthand, modified oligos and modified oligonucleotides need more than desalting, what oligo modifications, phosphorothioate oligonucleotides, a nucleoside phosphoramidite, the nucleoside phosphoramidites and phosphoramidites behind them actually cost, where oligo synthesis services, dna oligo synthesis, oligos synthesis, oligonucleotides synthesis, custom oligonucleotide synthesis, primer synthesis, the oligo synthesis companies offering it, large-scale oligo synthesis, large scale oligonucleotide synthesis, long oligo synthesis, oligo pool synthesis, oligo pools, oem oligos, gmp oligos, gmp rna and dna manufacturing at a quality agreement become different products, how rna purification after synthesis changes what arrives, and how primer ordering, ordering primers, a primer order, oligo primers, custom pcr primers and the habit of order primers or order primers for pcr in plates, then order pcr primers again from the same file, keeps a laboratory in resuspension buffer such as idte without a freezer full of duplicates

An oligonucleotide is priced by the base, quoted by the synthesis scale and delivered at a purity someone chose on your behalf unless you state one. Those three variables move the cost of the same sequence by an order of magnitude, and they are the difference between a primer that works in a routine reaction and a probe that has to survive a clinical assay. This page sets out what actually changes when the order form changes, so a specification can be written once and reused.

the FDA rule that decides what an electronic order and result record must hold
Part 11
good laboratory practice for nonclinical studies, 21 CFR
Part 58
the labelling clause behind research use only on a synthesised reagent
809.10(c)

The figures in this panel are regulatory clause identifiers, named from the regulations themselves and linked below. They are not prices: BioBricks publishes verified prices for synthesis services only, and does not imply an oligonucleotide price index it has not measured.

Writing the order

  1. Set the scale from the use, not from the catalogue default. Synthesis scale decides how much material you receive, and most laboratories order far more than a PCR programme will ever consume. A small scale covers years of routine primer use; a probe going into a validated assay, or a guide going into a screen, is where a larger scale and a second synthesis lot earn their cost. Ordering the smallest scale that covers the work removes freezer clutter and makes reordering a deliberate act.
  2. Choose purification against the reaction, not against a grade name. Desalted material is right for standard amplification. Cartridge and HPLC purification remove the truncated failure sequences that matter when a labelled probe, a long assembly fragment or an antisense construct has to behave predictably. Gel purification is the choice when full length is the only acceptable product. Every step up in purification costs yield, so buy it where a shortened sequence would change a result.
  3. Declare modifications early and in full. A five prime label, a three prime quencher, a phosphorothioate backbone, a spacer or a locked base each change the coupling chemistry and often the minimum scale. Suppliers quote them differently, and a modification that looks minor can double a lead time. List every modification with its position in the sequence and ask which ones force a purification you would not otherwise buy.
  4. Order in plates when the set is a set. A screening panel, a tiling set or a library of variants belongs in a plate at a stated concentration in a stated buffer, not in ninety six individual tubes. Plate orders arrive normalised, cost less to handle and make the downstream automation trivial. State the buffer explicitly: a low EDTA tris buffer is the common default and it is not the same as water for long term storage.
  5. Fix a storage and resuspension rule for the laboratory. Dried oligonucleotides are stable for a long time at low temperature; resuspended stocks are not, and repeated freezing and thawing is the usual cause of a primer that stopped working. Agree one resuspension concentration, one buffer and one aliquoting habit, and write them where the plate lives.

Why the same sequence is quoted three ways

Suppliers publish a per base price that applies at one scale and one purification, and everything else is a surcharge. Compare two quotations and you are usually comparing different scales, different purities and different assumptions about whether a modification is included. Rewriting both onto your own specification, with the scale, the purification and every modification stated, is the only way to see which is cheaper.

Lead time behaves the same way. A standard desalted order ships in a day or two; a modified, HPLC purified sequence at a larger scale can take a week, and a manufacturing grade order to a quality agreement takes considerably longer. If a project has a fixed date, the lead time is part of the specification and belongs in the purchase order.

Where research grade stops being enough

Research use material carries the supplier's own quality system and a certificate of analysis that states identity and purity. Material destined for a regulated process needs more: a documented manufacturing process, controlled changes, retained samples and an agreement that says what happens when a lot fails. That is a different product line at a different price, and asking for it late is expensive.

The practical signal is whether anyone downstream will have to defend the reagent. If the answer is yes, buy the graded product from the start and keep the records with the batch, because retrofitting provenance onto a research lot is rarely possible.

Keeping a plate order useful a year later

A plate of sequences is only as good as the file that describes it. Keep the well map, the sequence list, the modification list, the synthesis lot and the resuspension buffer together in one record that survives the person who placed the order, and give the plate an identifier that appears on both the file and the physical label.

Laboratories that get this right reorder by editing a file. Laboratories that do not end up resynthesising sequences they already own, which is the most avoidable cost in this category.

Common questions

What actually drives the price of an oligonucleotide?
Scale, purification and modification, in that order, with length as a secondary factor. Two quotations for the same sequence are rarely comparable until all three are stated, which is why a written specification is worth more than a price list.
When is desalted material not good enough?
When a truncated sequence would change the result: labelled probes, long assembly fragments, antisense and therapeutic constructs, and anything going into a validated method. Routine amplification primers are usually fine desalted.
Should I order oligo pools or individual tubes?
A pool is the right product when the set is used together and never individually, for example a screening library or a tiling panel. Individual synthesis is right when each sequence has to be tracked, quantified and reordered on its own.
What should oligonucleotides be resuspended in?
A buffered low EDTA tris solution rather than water for stocks you intend to keep, with working dilutions made fresh. Fix one concentration and one buffer across the laboratory so nobody has to interpret a tube label.

Get a shortlist for your project

Free. We send a shortlist of vendors whose published prices and service scope fit what you described, built from the verified index on this site. We may email you about this enquiry and similar services from this site; opt out any time, including from the first message.

Browse by service class

Sources

Cite or embed this figure

The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.

Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/oligonucleotide/.

Embed this figure (plain HTML, no scripts)
median advertised gene synthesis price per base pair · the US research synthesis services market · August 2026

$0.11

Middle 50%$0.07 – $0.15
verified vendor service pages4

Source: BioBricks Synthesis Price Index

Get a vendor shortlistCompare synthesis prices